NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL)

07 Apr 2026 17:35 CEST

The shareholders of ContextVision AB (publ), reg. no. 556377-8900, are hereby
invited to the Annual General Meeting on Tuesday, 12 May 2026, at 14:00, at
the company's premises, Gamla Brogatan 26, Stockholm.

Participation and Notification etc.
Shareholders who wish to participate in the general meeting with the right to
vote shall

* be recorded as shareholder in the share register kept by Euroclear Sweden AB
on Monday, 4 May 2026, temporary registration for shareholders registered at
Norska Verdipapirsentralen (VPS) is made through DNB Bank ASA, see below;
and

* give notice of attendance to the company in writing at the latest on
Wednesday, 6 May 2026 (by e-mail: ir@contextvision.com or by post: Gamla
Brogatan 26, 111 20 Stockholm).

For the notification, the name, personal or organization number, address,
phone number, and shareholding should be stated. If a shareholder is
represented by a proxy, a written and dated power of attorney must be issued
for the proxy. Proxy forms are available on the company's website as set out
below. If the power of attorney has been issued by a legal entity, a
registration certificate or equivalent authorization document must be
attached. Original power of attorney as well as registration certificate and
other authorization documents must be presented no later than upon entry to
the general meeting.

In order to be entitled to participate in the meeting, a shareholder who has
had his shares registered in Sweden in addition to give notice of
participation in the meeting must have the shares registered in his own name
so that the shareholder is entered in the share register as of 4 May 2026.
Such registration may be temporary (so-called voting rights registration) and
is requested from the nominee according to the nominee's routines at such time
in advance as the nominee decides. Voting rights registrations made no later
than 6 May 2026 are taken into account in the production of the share
register.

Particular for shareholders registered at Norska Verdipapirsentralen
(VPS)

* Shareholders registered at Norska Verdipapirsentralen (VPS) who are not
registered with Euroclear Sweden AB, Sweden, and wish to be entitled to vote
at the General Meeting must give notice of attendance to DNB Bank ASA no
later than 30 April 2026 at 12:00 local time. The notice of attendance is
made on a specific registration form which is sent by post to the
shareholders and is also provided on the company's website. The notice of
attendance shall be sent to DNB Bank ASA, Securities Services, PO Box 1600
Sentrum, N-0021 Oslo, or via e-mail vote@dnb.no.
* DNB Bank ASA will temporarily register the shares with Euroclear Sweden AB
in the name of the shareholder. Shareholders registered with VPS must also
give notice of attendance with the company as described above in order to
receive voting rights at the General Meeting. Shareholders registered with
VPS who only have given notice of attendance to the company may participate
in the General Meeting without voting rights.

For information on how your personal data is processed, please see

https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pd
f
(http://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pd
f)

At the time of issuing this notice to the general meeting, the company has in
total 77,367,500 shares, corresponding to in total 77,367,500 votes. The
company holds 2,622,664 treasury shares.

The shareholders are reminded of their right to request certain information
from the board of directors and the managing director in accordance with
chapter 7 section 32 of the Swedish Companies Act.

Agenda
1. Election of the chairman of the meeting
2. Preparation and approval of the voting list
3. Election of one or two persons to certify the minutes
4. Consideration of whether the meeting has been duly convened
5. Approval of the agenda
6. Presentation of annual report and auditor's report as well as of the
consolidated financial statements and the auditor's report for the group
7. Resolution regarding:
a) adoption of the income statement and the balance sheet as well as the
consolidated income statement and the consolidated balance sheet
b) appropriation of the company's profit or loss in accordance with the
adopted balance sheet
c) discharge from liability of members of the board of directors and the
managing director
8. Determination of the number of board members and deputy board members and
auditors and deputy auditors
9. Election of the board of directors and the auditors
10. Determination of fees for the board of directors and the auditors
11. Proposal regarding principles for the appointment of a nomination
committee and instruction to the nomination committee
12. Resolution regarding approval of the remuneration report
13. The board of directors' proposal on authorization of the board of
directors to resolve to issue new shares
14. The board of directors' proposal to authorize the board of directors to
resolve on the acquisition of the company's own shares
15. The board of directors' proposal on a Long-Term Incentive Program 2026
(LTIP 2026)
16. Conclusion of the meeting

1. Election of Chairman of the Annual General Meeting
The nomination committee proposes that the Chairman of the Board, Olof Sandén,
or the person proposed by the board of directors if he has an impediment to
attend, is elected Chairman of the Annual General Meeting.

7 B. Resolution regarding appropriation of the company's profit or loss
in accordance with the adopted balance sheet
The board of directors proposes that no dividend shall be distributed for the
financial year 2025 and that the company's result shall be carried forward in
the new accounts.

8. Determination of the number of board members and deputy board members
and auditors and deputy auditors
The nomination committee proposes that the board of directors, for the period
up until the end of the next annual general meeting, shall be composed of four
directors with no deputy directors.

It is proposed that one registered accounting firm is elected as auditor.

9. Election of the board of directors and the auditors
The nomination committee proposes that the board members Olof Sandén, Martin
Ingvar, and Christer Ljungberg shall be re-elected for the period up until the
end of the next annual general meeting. The nomination committee proposes
further that Homer Pien shall be elected as a new board member for the period
up until the end of the next annual general meeting. In addition, the
nomination committee proposes that Olof Sandén shall be re-elected as chairman
of the board of directors for the period up until the end of the next annual
general meeting.


+--------------------+-------------------------------------------------------+
| Name: | Homer Pien. |
+--------------------+-------------------------------------------------------+
| Year of birth: | 1963. |
+--------------------+-------------------------------------------------------+
| Education: | Homer Pien holds a B.S. in Mathematics from the |
| | University of Illinois, M.S. and Ph.D. in Computer |
| | Science from Northeastern University, and a M.S. in |
| | Business Management from the Massachusetts Institute |
| | of Technology. |
+--------------------+-------------------------------------------------------+
| Experience: | Homer Pien has extensive experience from senior |
| | leadership roles in global technology and healthcare |
| | organizations. He most recently served as Senior Vice |
| | President and Chief Scientific Officer at Philips |
| | within the Precision Diagnosis business cluster and |
| | previously as Chief Technology Officer for Philips |
| | Imaging Systems. Before joining Philips, he led the |
| | Laboratory for Medical Imaging and Computations at |
| | Massachusetts General Hospital and Harvard Medical |
| | School. His earlier career included roles at MIT |
| | Lincoln Laboratory, Draper Laboratory, and serving as |
| | co founder, CEO, and CSO of a biotechnology start up. |
| | He has also held multiple board assignments in the |
| | MedTech and digital health sectors. |
+--------------------+-------------------------------------------------------+
| Other assignments: | Homer Pien currently serves on the boards of several |
| | medical device and AI companies, including Cerebriu, |
| | RadPaiR, Wellist, and Frond Medical. He previously |
| | served on the board of the Swedish prostate cancer |
| | company SpectraCure AB. |
+--------------------+-------------------------------------------------------+
| Independence: | Homer Pien is independent in relation to the company |
| | and its management and in relation to the company's |
| | major shareholders. |
+--------------------+-------------------------------------------------------+


For information regarding the board members proposed for re-election,
reference is made to the annual report for 2025.

It is proposed that the accounting firm Grant Thornton shall be re-elected as
auditor for the period up until the end of the next annual general meeting.
Grant Thornton has announced that the authorized public accountant, Joakim
Söderin, will be the responsible auditor.

10. Determination of fees for the board of directors and the auditors
The nomination committee proposes that fees to the board of directors, for the
period up until the end of the next annual general meeting, shall amount to a
total of SEK 1,189,000 with the following distribution: SEK 400,000 to the
chairman of the board of directors (unchanged from the previous year) and SEK
263,000 to each of the other members of the board of directors (unchanged from
the previous year).

Furthermore, it is proposed that the fee to the auditor, for the period up
until the end of the next annual general meeting, shall be paid as incurred.

11. Proposal regarding principles for the appointment of a nomination
committee and instruction to the nomination committee
The nomination committee proposes that the general meeting resolve that a
nomination committee for the annual general meeting 2027 shall be appointed in
accordance with the following.

Principles for the appointment of a nomination committee and instruction to
the nomination committee

1. Election of members etc.

1.1. The chairman of the board of directors shall - by the end of the third
quarter 2026 at the latest - contact the three largest registered shareholders
or otherwise known shareholders as of August 31, and ask them to appoint one
member each to be part of the nomination committee. If one shareholder
refrains from appointing a member to the nomination committee, the shareholder
next in line, according to shareholding, shall be asked to appoint a member of
the nomination committee. The term of office shall run until the next
nomination committee has taken office.

1.2. The nomination committee shall consist of at least four members,
including the chairman of the board of directors.

1.3. The chairman of the board of directors is the convenor of the nomination
committee's first meeting. For the continued work, a chairman of the
nomination committee shall be appointed within the nomination committee. The
chairman of the nomination committee shall not be the chairman of the board of
directors.

1.4. The composition of the nomination committee shall be announced no later
than six months before the annual general meeting. Through this procedure, all
shareholders shall be made aware of which persons that may be contacted
regarding nomination matters.

1.5. The nomination committee shall fulfill the obligations stated in the
Swedish Corporate Governance Code as well as propose a procedure for the
election of a new nomination committee. The nomination committee may, within
itself and through adjunction of the required additional member(s), appoint a
specific nomination committee responsible for the appointment of auditors (in
accordance with Section 2.1 below). If such a nomination committee is
appointed, this shall be announced in accordance with what is stated above in
Section 1.4.

1.6. Should a shareholder, who appointed a member of the nomination committee,
sell a substantial part of its shares in the company before the nomination
committee's work is fulfilled, the appointed member shall, upon decision of
the nomination committee, resign and be replaced by a new member appointed by
the shareholder who at the time is the largest registered shareholder or
otherwise known shareholder not represented in the nomination committee.
Should any member of the nomination committee no longer represent the
shareholder who appointed the member before the nomination committee's work is
fulfilled, such member shall, upon decision of the nomination committee, be
replaced by new member appointed by the shareholder. Upon decision of the
nomination committee, amendments of the composition of the nomination
committee shall be done in accordance with the principles stated above in the
event that the ownership of the company, in other cases than referred to
above, substantially change before the nomination committee's work is
fulfilled.

2. The task of the nomination committee

2.1. The nomination committee shall prepare and propose decisions to the
general meeting regarding:

- Election of chairperson of the general meeting
- Resolution regarding the number of members of the board of directors
- Election of and resolution regarding fees to the chairperson of the board of
directors and the members of the board of directors, respectively
- Election of and resolution regarding fees to the auditor and deputy auditor
(if applicable)
- Election of and resolution regarding fees to the members of any other
specific committee that the general meeting may resolve to appoint
- Procedure for election of a new nomination committee

2.2. The nomination committee's proposed resolutions shall be submitted to the
company through the chairperson of board of directors no later than six weeks
before the general meeting where election of the board of directors and
auditor shall take place. The proposed resolutions shall, as far as possible,
include all the necessary information in order for the company to fulfil its
information obligations under the Swedish Companies Act, marketplace rules,
good practice on the stock market and other applicable rules/recommendations.

2.3. The chairperson of the board of directors shall, in an appropriate
manner, inform the nomination committee regarding the board of directors
competence profile and work methods.

3. Meetings

3.1. The nomination committee shall convene when necessary in order for the
nomination committee to fulfil its tasks, however, at least once a year during
each term. The notice to the meeting shall be issued by the chairperson of the
nomination committee (exemption in Section 1.3). A member of the nomination
committee may request that the nomination committee convene.

3.2. The nomination committee has a quorum when at least half of the members
are participating in a meeting. However, the nomination committee may not
resolve on any issue if all the members of the nomination committee have not
been afforded the opportunity to participate in the business of the meeting.
The decision made by the nomination committee is the decision voted for by the
majority of members present, or, when there is a tie, the chairperson of the
nomination committee shall cast the deciding vote.

3.3. The nomination committee shall keep minutes of its meetings. The minutes
shall be signed by the chairperson of the nomination committee and adjusted by
a member appointed by the nomination committee. Minutes shall be stored in
accordance with what is stated regarding minutes of meetings of the board of
directors.

12. Resolution regarding approval of the remuneration report
The board of directors proposes that the general meeting resolves to approve
the remuneration report for the financial year 2025.

13. The Board of Directors' proposal on authorization of the Board of
Directors to resolve to issue new shares
The board of directors proposes that the annual general meeting resolves to
authorize the board of directors, for the period up until the 2027 annual
general meeting, whether on one or several occasions, to adopt resolutions to
issue new shares, with or without deviation from the shareholders'
preferential rights. Such new issue resolutions may include provisions of
payment in cash and/or payment by way of contribution of non-cash
consideration or by set-off of a claim or that subscription shall be subject
to other conditions. The board of directors may otherwise set the terms of
such new issue resolutions. The issue price shall be determined on market
terms, and the number of issued shares may amount to not more than ten (10)
percent of the number of outstanding shares on the day of this notice.

Deviation from the shareholders' preferential rights, as well as the
authorisation to resolve on issuances against cash payment and/or with
provisions on contribution in kind or set-off, or otherwise on terms deviating
from the shareholders' preferential rights, is intended to enable the issuance
of shares in connection with acquisitions of shares or businesses. Further
reasons for the deviation from the preferential rights are to strengthen the
company's financial position, where appropriate, and to broaden the
shareholder base.

Majority requirements
A valid resolution requires that the proposal is supported by shareholders
representing at least two-thirds (2/3) of the votes cast as well as of all
shares represented at the General Meeting.

14. The board of directors' proposal to authorize the Board of Directors
to resolve on the acquisition of the company's own shares
The board of directors proposes that the general meeting resolves to authorize
the board of directors, for the period up until the 2027 annual general
meeting, to resolve on the acquisition of own shares in the company in
accordance with the following conditions:

1. The acquisition may involve up to 4,000,000 shares in the company for an
amount not exceeding NOK 12,000,000.
2. The acquisition of shares may be made through trading on Euronext Oslo
Stock Exchange (the "Exchange") or through an offer directed to all
holders of shares in the company.
3. Shares may only be acquired on the Exchange at a price per share that does
not exceed the higher of: a) the last independent trade in the company's
share; and b) the highest current bid for the company's share on the
Exchange.
4. Shares may only be acquired through an offer directed to all holders of
shares in the company at a price per share which, at the time of the
offer, does not exceed the market value by 20 percent or is 20 percent
below the market value at the time of the offer.
5. Payment for the shares shall be made in cash.
6. This authorization may be utilized on one or several occasions up until
the 2027 annual general meeting.

The purpose of the above authorization is to reduce the capital of the issuer
and/or to meet obligations arising from the company's Long-Term Incentive
Programs (LTIP). The board of directors has proposed that the general meeting
shall resolve on the introduction of a new Long-Term Incentive Program 2026,
that is subject to a separate resolution under item 15 of this notice to this
general meeting.

Majority Requirement
A valid resolution requires the approval of shareholders representing
two-thirds (2/3) of both the votes cast and the shares represented at the
general meeting.

15. The board of directors' proposal for resolution regarding Long-Term
Incentive Program 2026 (LTIP 2026)
The board of directors proposes that the general meeting resolves on the
implementation of a long-term incentive program 2026 ("LTIP 2026"). This
proposal is divided into four items:

A. Terms of LTIP 2026.
B. Hedging measures regarding LTIP 2026 through the transfer of treasury
shares.
C. Hedging measures regarding LTIP 2026 through an equity swap agreement with
a third party.
D. Other matters related to LTIP 2026.

A. Terms of LTIP 2026

A.1 Introduction
The board of directors want to implement a long-term incentive program for
current and future senior executives and other employees in the company or its
subsidiaries, in order to encourage a personal long-term ownership in the
company, and in order to increase and strengthen the potential for recruiting,
retaining and motivating such senior executives and other employees.
Therefore, the board of directors proposes that the general meeting resolves
on the implementation of LTIP 2026 for current and future senior executives
and other employees in the company or its subsidiaries.

Participants will, after a qualifying period, be given the opportunity to,
without consideration, receive allotment of ContextVision Shares (defined
below). The number of allotted ContextVision Shares will be dependent on the
fulfilment of certain performance requirements. ContextVision Shares are
ordinary shares in the company ("ContextVision Shares"). The term of LTIP 2026
is approximately three years.

A.2 Basic features of LTIP 2026
LTIP 2026 will be directed towards current and future senior executives and
other employees in the ContextVision Group. The participants are based in
Sweden and other countries where the ContextVision Group is active. The
participant shall be entitled, upon completion of a vesting period (defined
below), subject to continued employment (with the exception of so-called good
leavers), and depending on the fulfillment of the performance requirements
related to the company's Earnings Before Interest, Taxes, Depreciation and
Amortisation ("EBITDA"), during the financial years 2027-2029, and the
ContextVision Share's total shareholder return ("TSR"), to receive allotment
of ContextVision Shares ("Performance Shares"). Participants shall not pay any
consideration for the allotted Performance Shares. Performance Shares are
ContextVision Shares.

A.3 Participation in LTIP 2026
LTIP 2026 is directed towards not more than fifty (50) current and future
senior executives and other employees in the company or its subsidiaries,
divided into three categories of participants:


+------------------------+-------------------------+-------------------------+
| Category | Maximum number of | Maximum number of |
| | Performance Shares per | Performance Shares per |
| | person | category |
+------------------------+-------------------------+-------------------------+
| A) CEO, maximum 1 | 189,600 | 189,600 |
| person | | |
+------------------------+-------------------------+-------------------------+
| B) Group Management | 47,400 | 142,200 |
| Team, maximum 3 | | |
| persons | | |
+------------------------+-------------------------+-------------------------+
| C) Other employees, | 47,400 | 1,066,500 |
| maximum 46 persons | | |
+------------------------+-------------------------+-------------------------+


New senior executives and other employees who are hired by the company or its
subsidiaries after the end of the initial application period may be offered to
participate in LTIP 2026. The remaining term of LTIP 2026 may be less than
three years upon the inclusion of such new senior executives and other
employees into LTIP 2026. The reason for the inclusion of new senior
executives and other employees after the end of the initial application period
is that it is considered to be of great value for the company and its
subsidiaries to quickly integrate new senior executives and other employees
into a corresponding incentive structure that applies to other senior
executives and other employees covered by LTIP 2026. However, the inclusion of
new senior executives and other employees into LTIP 2026 must not occur later
than 31 December 2026.

Any resolution on participation or implementation of LTIP 2026 shall be
conditional on that it, in the Board of Directors' judgement, can be offered
with reasonable administrative costs and financial effects.

A.4 Allotment of Performance Shares
Allotment of Performance Shares within LTIP 2026 will be made during a limited
period of time following the announcement of the quarterly report for the
fourth quarter of 2029. The period up to this date is referred to as the
qualification period ("vesting period"). If the participant and/or the company
is prevented from carrying out the allotment of Performance Shares due to, for
example, insider information, the company has the right to extend the period
for allotment so that it runs until a date when such obstacle has ceased and
allotment can take place.

In order for the participant to be entitled to receive allotment of
Performance Shares, it is assumed that the participant remains an employee of
the ContextVision Group during the full qualification period up until
allotment (with the exception of so-called good leavers), and that the
performance requirements related to the company's EBITDA and/or TSR has been
fulfilled.

The Participant can receive allotment of the maximum number of Performance
Shares set out in the table above. Of the maximum number of Performance Shares
that can be allotted per person, fifty (50) percent of the Performance Shares
shall be linked to the fulfillment of the performance requirement regarding
EBITDA and fifty (50) percent of the Performance Shares shall be linked to the
fulfillment of the performance requirement regarding TSR. The two performance
requirements will be determined by the board of directors with a minimum and a
maximum level for each performance requirement. For stock market and
competitive reasons, the minimum and maximum level for the performance
requirement EBITDA are not specified. No allotment of Performance Shares
linked to a certain performance requirement will take place below the minimum
level for such performance requirement. Full allotment of Performance Shares
linked to a certain performance requirement will take place at or above the
maximum level of such performance requirement. The number of Performance
Shares that can be allotted increases linearly between the minimum and maximum
levels of the respective performance requirements.

A.4.1 EBITDA (weighting 50 percent)
The performance requirement is based on the ContextVision Group's EBITDA
during the financial years 2027-2029.

A.4.2 TSR (weighting 50 percent)
The performance requirement is based on the total shareholder return per
ContextVision Share based on the volume-weighted average price according to
Euronext Oslo Stock Exchange's official price list for the ContextVision Share
during the first fifteen (15) trading days that directly follows the annual
general meeting 2026 compared with the volume-weighted average price according
to Euronext Oslo Stock Exchange's official price list for the ContextVision
Share during the fifteen (15) trading days that immediately follows the
announcement of the quarterly report for the fourth quarter of 2029, i.e. a
calculation of the increase in percentages in the share price for the
ContextVision Share, whereby the closing price shall be calculated to take
into account any dividends paid during the above-mentioned time period
according to the current methodology used when calculating total shareholder
return.

A.5 Limitation of allotment etc.
Before allotment of Performance Shares, the board of directors shall assess
whether the allotment is reasonable in relation to the company's financial
results, position and development, as well as other factors. If significant
changes take place within the company, or on the market, which, by the
assessment of the board of directors, would mean that the terms for
allotment/transfer of Performance Shares according to LTIP 2026 is no longer
reasonable, the board of directors shall have the right to amend LTIP 2026,
including, among others, the right to reduce the number of
allotted/transferred Performance Shares, or not to allot/transfer any
Performance Shares at all.

A.6 Implementation and administration etc.
The board of directors shall, in accordance with the resolutions by the
general meeting set forth herein, be responsible for the detailed design and
implementation of LTIP 2026. The board of directors may also decide on the
implementation of an alternative cash-based incentive for participants in
countries where the allotment of Performance Shares is not possible, as well
as if otherwise considered appropriate. Such alternative incentive shall to
the extent practically possible be designed to correspond to the terms of LTIP
2026. The intention is that the board of directors shall launch LTIP 2026 as
soon as practically possible following the general meeting.

In the event that the general meeting does not resolve in accordance with item
B with the required majority, the company shall hedge itself against the
financial exposure that LTIP 2026 is expected to entail, by entering into a
share swap agreement with a third party in accordance with what is stated in
item C below.

B. Hedging measures regarding LTIP 2026 through the transfer of treasury
shares

B.1 Approval of transfer of ContextVision Shares
The board of directors proposes that the general meeting resolve to approve
the transfer of ContextVision Shares owned by the company on the following
terms and conditions:

a) A maximum number of 1,398,300 ContextVision Shares may be transferred free
of charge to participants within LTIP 2026 at the time and subject to the
other conditions under which participants in LTIP 2026 have the right to be
allotted ContextVision Shares.

b) The number of ContextVision Shares that might be transferred under LTIP
2026 shall be subject to customary re-calculation principles and may,
consequently, be subject to re-calculation due to a bonus issue, share split,
rights issues, dividends and/or other similar events. Resolutions resolved
upon by this general meeting or, if applicable, based on an authorization from
this general meeting shall not be included in a re-calculation of the number
of ContextVision Shares.

c) It is noted that a proposal regarding an authorization for the board of
directors to resolve on transfer of ContextVision Shares on Euronext Oslo
Stock Exchange will be proposed by the board of directors prior to the annual
general meeting 2028, 2029, and 2030, in order to hedge the cash flow related
to the company's payments of social security contributions in relation to LTIP
2024, LTIP 2025, and LTIP 2026.

B.2 The basis for the board of directors' proposal
Since the board of directors considers that the most cost-effective method of
transferring ContextVision Shares under LTIP 2026 is to transfer ContextVision
Shares owned by the company, the board of directors proposes that the transfer
is hedged in this way in accordance with this item B. Should the necessary
majority not be obtained for the proposal in item B, the board of directors
will enter into a share swap agreement, in accordance with item C below. A
share swap agreement will also be relevant should this be more appropriate,
for example due to the fact that the acquisition of own shares cannot be made
to the extent required to be able to transfer shares under LTIP 2026.

C. Hedging measures regarding LTIP 2026 through an equity swap agreement with
a third party
In the event that the necessary majority is not obtained for item B above, the
company will hedge itself against the financial exposure that LTIP 2026 is
expected to entail, by the company entering into a share swap agreement with a
third party, whereby the third party in its own name shall acquire and
transfer ContextVision Shares regarding LTIP 2026. The relevant number of
ContextVision Shares shall correspond to the number of shares proposed under
item B above.

D. Other matters in relation to LTIP 2026

D.1 Majority requirements etc.
A valid resolution under item A above (including item C) requires a majority
of more than half of the votes cast at the general meeting.

A valid resolution under item B above requires that shareholders representing
not less than nine-tenths (90%) of the votes cast as well as the shares
represented at the general meeting approve the resolution.

D.2 Estimated costs, expenses and financial effects of LTIP
The costs for LTIP 2026 which are charged in the profit and loss account, are
calculated according to the accounting standard IFRS 2 and distributed over
the vesting period. The calculation has been made based on the closing price
of the ContextVision share according to Euronext Oslo Stock Exchange's
official price list for the ContextVision Share 26 March 2026, i.e. NOK 3.30
per share, and the following assumptions: (i) an estimated annual turnover of
personnel of 10 percent, (ii) a fulfilment of the performance requirements of
approximately 50 percent, (iii) an assessment of the future volatility of the
ContextVision Shares, (iv) that a total maximum of 1,398,300 Performance
Shares are eligible for allotment, and (v) an exchange rate NOK/SEK of 0.97.
In addition to what is set forth above, the costs for the LTIP 2026 have been
based on that the program comprises a maximum of 50 participants.

In total, the costs for LTIP 2026 according to IFRS 2 are estimated to
approximately MSEK 1.6 excluding social security costs (MSEK 2.3 if the
fulfilment of the performance conditions is 100 percent). The costs for social
security charges are calculated to approximately MSEK 0.7, based on the above
assumptions, and also assuming a TSR of approximately 12 percent during the
vesting period of LTIP 2026 and a social security tax rate of 30 percent
(MSEK 1.8 if the fulfilment of the performance conditions is 100 percent, as
well as a yearly TSR of approximately 20 percent during LTIP 2026).

The expected annual costs of MSEK 0.6, including social security charges,
correspond to approximately 1.0 percent of the Group's total employee costs
for the financial year 2025 (approximately 1.8 percent if the fulfilment of
the performance conditions is 100 percent).

As proposed, LTIP 2026 may comprise a maximum of 1,398,300 shares in
ContextVision. Together with additional 419,500 shares that may be transferred
on Euronext Oslo Stock Exchange in order to hedge the cash flow related to the
company's payments of social security contributions associated with LTIP 2026,
the total number of shares amounts to 1,817,800. This corresponds to
approximately 2.3 percent of all shares and votes in ContextVision.

The expected cost for advisory fees in order to ensure delivery of shares to
participants through acquisition and transfer of ContextVision Shares is
approximately SEK 300,000. The cost for a share swap arrangement with a third
party is higher and based on an interest base with an addition for the
company's lending costs, taking into account the structure of the share swap
derivative.

Given the above assumptions regarding costs and that LTIP 2026 was introduced
in 2024 instead, it is estimated that the key ratio earnings per share for the
full year 2025 would have decreased from SEK 0.01 per share to SEK 0.00 per
share, based on the average number of outstanding shares. Similarly, equity
per share would have decreased from SEK 1.22 per share to SEK 1.21 per share,
based on the number of shares outstanding at year-end.

D.3 The board of directors' statement
The board of directors wishes to increase the ability of the company and its
subsidiaries to recruit and retain key senior executives and other employees.
Moreover, an individual long-term ownership commitment among the participants
in LTIP 2026 is expected to stimulate greater interest and motivation in the
company's business operations, results and strategy. The board of directors
believes that the implementation of LTIP 2026 will benefit the company and its
shareholders. LTIP 2026 will provide a competitive and motivation-improving
incentive for key senior executives and other employees within the company and
its subsidiaries.

LTIP 2026 has been designed to reward the participants for increased
shareholder value by allotting ContextVision Shares, based on the fulfilment
of result based conditions and conditions linked to increased shareholder
value. By linking the employees' remuneration to an improvement in
ContextVision's results and value, the long-term value growth of ContextVision
is rewarded. Based on these circumstances, the board of directors considers
that the implementation of LTIP 2026 will have a positive effect on the
company's continued development, and will thus be beneficial to the
shareholders and the company.

D.4 Preparation of the item
The basis for LTIP 2026 has been prepared by the board of directors of the
company. The work has been supported by external advisors and has been made in
consultation with shareholders. The board of directors has thereafter decided
to present this proposal for the general meeting. Except for the staff that
have prepared the matter upon instruction from the board of directors, no
employee that may be a participant of the program has participated in the
preparations of the program's terms.

D.5 Other share-related incentive programs
The company's other share-related incentive programs are described on page 56
in the company's annual report 2025.

Documents
The Annual Report and other documents pursuant to the Swedish Companies Act as
well as proxy forms will be kept available at the company's office, Gamla
Brogatan 26, Stockholm, and at the company's website, www.contextvision.se no
later than on 21 April 2026 and will also be sent to shareholders that so
request and state their address.

N.B. This English version of the notice to the Annual General Meeting is an
unofficial translation. In case of any discrepancies in relation to the
Swedish version of the notice to the Annual General Meeting, the Swedish
version shall prevail.

Stockholm in April 2026
CONTEXTVISION AB (PUBL)
The Board of Directors

For more information, please contact:
ir@contextvision.com

About ContextVision
ContextVision is a software company specialized in image analysis and
artificial intelligence. As the global market leader within image enhancement,
we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI
equipment around the world. Our expertise is to develop powerful software
products, based on proprietary technology and artificial intelligence for
image-based applications. Our cutting-edge technology helps clinicians
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on
the Oslo Stock Exchange under the ticker CONTX.

More information:
Access the news on Oslo Bors NewsWeb site

670080_ContextVision Board Of Directors' Statement Regarding Repurchase Of Own Shares.pdf
670080_ContextVision Notice To The Annual General Meeting 2026.pdf
670080_NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL).pdf
670080_ContextVision Remuneration Report 2025.pdf